Summary
The aetiology of late-onset bipolar disorder is heterogeneous because the disease is more likely to have a secondary (i.e. a medical disorder or medication-induced) cause in older than in younger patients. Elderly patients with bipolar disorder typically require lithium dosages that are 25 to 50% lower than those used in younger individuals. Information on the use of valproic acid (sodium valproate) in elderly patients with bipolar disorder is limited but encouraging. In contrast, there is virtually no information regarding the use of carbamazepine or other drugs in this patient group. Electroconvulsive therapy is well tolerated by older people and can be useful for these patients.
Similar content being viewed by others
References
National Institute on Aging. Personnel for health needs of the elderly through year 2020. Bethesda (MD): US Department of Health and Human Services, 1987
Jeste DV, Harris MJ, Krull A, et al. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry 1995; 152(5): 722–30
Young RC, Klerman GL. Mania in late-life: focus on age at onset. Am J Psychiatry 1992; 149: 867–76
Kramer M, German PS, Anthony JC, et al. Patterns of mental disorders among the elderly residents of eastern Baltimore. J Am Geriatr Soc 1985; 33(4): 236–45
Yassa R, Nair V, Nastase C, et al. Prevalence of bipolar disorder in a psychogeriatric population. J Affect Disord 1988; 14: 197–201
Stevick CP. Some demographic and diagnostic characteristics of a geriatric population in a state geriatric facility. J Am Geriatr Soc 1980; 28(9): 426–9
Snowdon J. A retrospective case-note study of bipolar disorder in old age. Br J Psychiatry 1991; 158: 485–90
Loranger AW, Levine PM. Age at onset of bipolar affective illness. Arch Gen Psychiatry 1978; 35: 1345–8
Summers WK. Mania with onset in the eighth decade: two cases and a review. J Clin Psychiatry 1983; 44: 141–3
Walter-Ryan WG. Mania with onset in the ninth decade [letter]. J Clin Psychiatry 1983; 44: 430–1
Ghadirian AM, Lalinec-Michaud M, Engelsmann F. Early and late onset affective disorders: clinical and family characteristics. Ann R I C P 1986; 19: 53–7
James NM. Early and late onset bipolar affective disorder: a genetic study. Arch Gen Psychiatry 1977; 34: 715–7
Taylor MA, Abrams R. Manic states: a genetic study of early and late onset affective disorders. Arch Gen Psychiatry 1973; 28: 656–8
Hopkinson G. A genetic study of affective illness in patients over 50. Br J Psychiatry 1964; 110: 244–54
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
Shulman K, Post F. Bipolar affective disorder in old age. Br J Psychiatry 1980; 136: 26–32
Rice J, Reich T, Andreasen NC, et al. The familial transmission of bipolar illness. Arch Gen Psychiatry 1987; 44(5): 441–7
Carlson GA, Davenport YB, Jamison K. A comparison of outcome in adolescent- and late-onset bipolar manic-depressive illness. Am J Psychiatry 1977; 134(8): 919–22
Young RC, Falk JR. Age, manic psychopathology and treatment response. Int J Geriatr Psychiatry 1989; 4: 73–8
Dhingra U, Rabins P. Mania in the elderly: a 5–7 year follow-up. J Am Geriatr Soc 1991; 39: 581–3
Kocsis JH, Shaw ED, Stokes PE, et al. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993; 13(4): 268–76
Wood K, Harris MJ, Morreale A, et al. Drug induced psychosis and depression in the elderly. Psychiatr Clin North Am 1988; 11: 167–93
Rego MD, Giller EL. Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia. J Clin Psychiatry 1989; 50: 143–4
Masand P, Stern TA. Bupropion and secondary mania: is there a relationship? Ann Clin Psychiatry 1993; 5: 271–4
Bittman BJ, Young RC. Mania in an elderly man treated with bupropion [letter]. Am J Psychiatry 1991; 148(4): 541
France RD, Krishnan KRR. Alprazolam-induced manic reaction. Am J Psychiatry 1984; 141: 1127–8
Pecknold JC, Fleury D. Alprazolam-induced manic episode in two patients with panic disorder. Am J Psychiatry 1986; 143: 652–3
Weilburg JB, Sachs G, Falk WE. Triazolam-induced brief episodes of secondary mania in a depressed patient. J Clin Psychiatry 1987; 48: 492–3
Price WA. Buspirone-induced mania. J Clin Psychopharmacol 1989; 9: 150–1
Liegghio NE, Yeragani VK. Buspirone-induced hypomania. J Clin Psychopharmacol 1988; 8: 226–7
Viswanathan R, Glickman L. Clonazepam in the treatment of steroid-induced mania in a patient after renal transplantation. N Engl J Med 1989; 320: 319–20
Bakish D, Lapierre YD. Disulfiram and bipolar affective disorder: acase report. J Clin Psychopharmacol 1986; 6(3): 178–80
Young RC, Moline M, Kleyman F. Hormone replacement therapy and late-life mania. Am J Geriatr Psychiatry 1997; 5(2): 179–81
Carney MWP. Switch and s-adenosylmethionine. Ala J Med Sci 1989; 25: 316–9
Adler LE, Sadja L, Wilets G. Cimetidine toxicity manifested as paranoia and hallucinations. Am J Psychiatry 1980; 137(9): 1112–3
Price W, Coli L, Brandstetter RD, et al. Ranitidine-associated hallucinations. Eur J Clin Pharmacol 1985; 29(3): 375–6
Ryback RS, Schwab RS. Manic response to levodopa therapy: report of a case. N Engl J Med 1971; 285(14): 788–9
Stoll AL, Mayer PV, Kolbrener M, et al. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151(11): 1642–5
Berthier ML, Kulvisevsky J. Fluoxetine-induced mania in a patient with post-stroke depression. Br J Psychiatry 1993; 163: 698–9
Turner SM, Jacob RG, Beidel DC, et al. A second case of mania associated with fluoxetine [letter]. Am J Psychiatry 1985; 142: 274–5
Ghaziuddin M. Mania induced by sertraline in a prepubertal child [letter]. Am J Psychiatry 1994; 151: 944
Jefferson JW, Greist JH, Perse TL, et al. Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder [letter]. J Clin Psychopharmacol 1991; 11: 391–2
Dorevitch A, Frankel Y, Bar-Halperin A, et al. Fluvoxamine-associated manic behavior — a case series. Ann Pharmacother 1993; 27: 1455–7
Sotsky SM, Tossell JW. Tolmetin induction of mania. Psychosomatics 1984; 25: 316–9
Kinzie JD, Lewinsohn P, Maricle R, et al. The relationship of depression to medical illness in an older community population. Compr Psychiatry 1986; 27(3): 241–6
Kwentus JA, Hart RP. Normal pressure hydrocephalus presenting as mania. J Nerv Ment Dis 1987; 175(8): 500–2
Kwentus JA, Hart RP, Calabrese V, et al. Mania as a symptom of multiple sclerosis. Psychosomatics 1986; 27(10): 729–31
Jamieson RC, Wells CE. Manic psychosis in a patient with multiple metastatic brain tumors. J Clin Psychiatry 1979; 40: 280–2
Cohen MR, Niska RW. Localized right cerebral hemisphere dysfunction and recurrent mania. Am J Psychiatry 1980; 137(7): 847–8
Jorge RE, Robinson RG, Starkstein SE, et al. Secondary mania following traumatic injury. Am J Psychiatry 1993; 150(6): 916–21
Yassa R, Cvejic J. Valproate in the treatment of posttraumatic bipolar disorder in a psychogeriatric patient. J Geriatr Psychiatry Neurol 1994; 7: 55–7
Steinberg D, Hirsch SR, Marston SD, et al. Influenza infection causing manic psychosis. Br J Psychiatry 1972; 120: 531–5
Binder RL, Dickman WA. Psychiatric manifestations of neurosyphilis in middle-aged patients. Am J Psychiatry 1980; 137(6): 741–2
Schwartz RB. Manic psychosis in connection with Q-fever. Br J Psychiatry 1974; 124: 140–3
Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry 1989; 154: 170–82
Fujikawa T, Yamawaki S, Touhouda Y. Silent cerebral infarctions in patients with late-onset mania. Stroke 1995; 26(6): 946–9
Goggans FC. A case of mania secondary to vitamin B12 deficiency. Am J Psychiatry 1984; 141(2): 300–1
Kovar MG. Health of the elderly and use of health services. Public Health Rep 1977 Jan/Feb; 92: 9–19
Philpott RM. Affective disorder and physical illness in old age. Int Clin Psychopharmacol 1990; 5Suppl. 3: 7–20
Irwin M, Daniels M, Weiner H. Immune and neuroendocrine changes during bereavement. Grief Bereavement 1987; 10(3): 449–65
Dunner DL. Differential diagnosis of bipolar disorder. J Clin Psychopharmacol 1992; 12(1 Suppl. 1): 7S–12S
Joyce PR. Age of onset in bipolar affective disorder and mis-diagnosis as schizophrenia. Psychol Med 1984; 14: 145–9
Glasser M, Rabins P. Mania in the elderly. Age Ageing 1984; 13: 210–2
Himmelhoch JM, Neil JF, May SJ, et al. Age, dementia, dyskinesias, and lithium response. Am J Psychiatry 1980; 137(8): 941–5
Stone K. Mania in the elderly. Br J Psychiatry 1989; 155: 220–4
Murray N, Hopwood S, Balfour DJK, et al. The influence of age on lithium efficacy and side-effects in out-patients. Psychol Med 1983; 13: 53–60
Van de Velde CD. Effectiveness of lithium carbonate in the treatment of manic-depressive illness. Am J Psychiatry 1970; 127: 345–51
O’Connell RA, Mayo JA, Flatow L, et al. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123–9
Angst J, Weis P, Grof P, et al. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970; 116(535): 604–14
Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand 1988; 78(6): 754–62
Hewick DS, Newbury P, Hopwood S, et al. Age as a factor affecting lithium therapy. Br J Clin Pharmacol 1977; 4: 201–5
Vestergaard P, Schou M. The effect of age on lithium dosage requirements. Pharmacopsychiatry 1984; 17: 199–201
Greil W, Stoltzenburg MC, Mairhofer ML, et al. Lithium dosage in the elderly: a study with matched age groups. J Affect Disord 1985; 9: 1–4
Wallin L, Ailing C, Aurell M. Impairment of renal function in patients on long-term lithium treatment. Clin Nephrol 1982; 18(1): 23–8
Hardy BG, Shulman KI, Mackenzie SE, et al. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol 1987; 7(3): 153–8
Chapron DJ, Cameron IR, White LB, et al. Observations on lithium disposition in the elderly. J Am Geriatr Soc 1982; 30: 651–5
Nielsen-Kudsk F, Amdisen A. Analysis of the pharmacokinetics of lithium in man. Eur J Clin Pharmacol 1979; 16: 271–7
Gerner RH. Treatment of acute mania. Psychiatr Clin North Am 1993; 16(3): 443–60
Scharfer CB, Garvey MJ. Use of lithium in acutely manic elderly patients. Clin Gerontol 1984; 3: 58–60
Young RC, Kalayam B, Tsuboyama G, et al. Mania: response to lithium across the age spectrum [abstract 669.4]. Society for Neuroscience Annual Meeting; Anaheim (CA); 1992 Oct 25–30: vol. 18
Mirchandani I, Young RC. Management of mania in the elderly: an update. Ann Clin Psychiatry 1993; 5(1): 67–77
Holroyd S, Rabins PV. A retrospective chart review of lithium side effects in a geriatric outpatient population. Am J Geriatr Psychiatry 1994; 2(4): 346–51
Nambudiri DE, Meyers BS, Young RC. Delayed recovery from lithium neurotoxicity. J Geriatr Psychiatry Neurol 1991; 4(1): 40–3
Foster JR, Silver M, Boksay IJE. Lithium in the elderly: a review with special focus on the use of intra-erythrocyte (RBC) levels in detecting serious impending neurotoxicity. Int J Geriatr Psychiatry 1990; 5: 1–7
Gelenberg AJ, Jefferson JW. Lithium tremor. J Clin Psychiatry 1995; 56(7): 283–7
Chacko RC, Marsh BJ, Marmion J, et al. Lithium side effects in elderly bipolar outpatients. Hillside J Clin Psychiatry 1987; 9(1): 79–88
Smith RE, Helms PM. Adverse effects of lithium therapy in the acutely ill elderly patient. J Clin Psychiatry 1982; 43(3): 94–9
Mitchell JE, Mackenzie TB. Cardiac effects of lithium in man: a review. J Clin Psychiatry 1982; 43: 47–51
Roose SP, Nurnberger JI, Dunner DL, et al. Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 1979; 136: 804–6
Roose SP, Bone S, Haidorfer C, et al. Lithium treatment in older patients. Am J Psychiatry 1979; 136(6): 843–4
Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995; 29(3): 172–91
Douste-Blazy P, Rostin M, Livarek B, et al. Angiotensin converting enzyme inhibitors and lithium treatment [letter]. Lancet 1986; I: 1448
Griffin JH, Hahn SM. Lisinopril-induced lithium toxicity [letter]. Drug Intell Clin Pharm 1991; 25: 101
Correa FJ, Eiser AR. Angiotensin-converting enzyme inhibitors and lithium toxicity. Am J Med 1992; 93: 108–9
Dubovsky SL, Franks RD, Allen S. Verapamil: a new anti-manic drug with potential interactions with lithium. J Clin Psychiatry 1987; 48(9): 371–2
Binder EF, Cayabyab L, Ritchie DJ, et al. Diltiazem-induced psychosis and a possible diltiazem-lithium interaction. Arch Intern Med 1991; 151: 373–4
Bruun NE, Ibsen H, Skott P, et al. Lithium clearance and renal tubular sodium handling during acute and long-term nifedipine treatment in essential hypertension. Clin Sci 1988; 75: 609–13
Macfie AC. Lithium poisoning precipitated by diuretics [letter]. BMJ 1975; 1(5956): 516
MacNeil S, Hanson-Nortey E, Paschalis C, et al. Diuretics during lithium therapy [letter]. Lancet 1975; I: 1295–6
Solomon JG. Lithium toxicity precipitated by a diuretic. Psychosomatics 1980; 21: 425–9
Kerry RJ, Ludlow JM, Owen G. Lesson of the week — diuretics are dangerous with lithium. BMJ 1980; 281: 371
Hurtig HI, Dyson WL. Lithium toxicity enhanced by diuresis [letter]. N Engl J Med 1974; 290(13): 748–9
Huang LG. Lithium intoxication with coadministration of a loop-diuretic [letter]. J Clin Psychopharmacol 1990; 10(3): 228
Oh TE. Frusemide and lithium toxicity. Anaesth Intensive Care 1977; 5(1): 60–2
Saffer D, Coppen A. Frusemide: a safe diuretic during lithium therapy? J Affect Disord 1983; 5(4): 289–92
Frolich J, Leftwich R, Ragheb M, et al. Indomethacin increases plasma lithium. BMJ 1979; 1: 1115–6
Reimann I, Frolich J. Effects of diclofenac on lithium kinetics. Clin Pharmacol Ther 1981; 30(3): 348–52
Shelley RK. Lithium toxicity and mefenamic acid. Br J Psychiatry 1987; 151: 847–8
Kerry RJ, Owen G, Michaelson S. Possible interaction between lithium and piroxicam. Lancet 1983; I: 418–9
Ragheb M. Ibuprofen can increase serum lithium level in lithium-treated patients. J Clin Psychiatry 1987; 48(4): 161–3
Iyer V. Ketorolac (Toradol) induced lithium toxicity. Headache 1994; 34: 442–4
Alderman CP, Lindsay KSW. Increased serum lithium concentration secondary to treatment with tiaprofenic acid and fosinopril. Ann Pharmacother 1996; 30: 1411–3
Ragheb M. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions. J Clin Psychopharmacol 1990; 10(5): 350–4
Ragheb M, Powell A. Failure of sulindac to increase serum lithium levels. J Clin Psychiatry 1986; 47(1): 33–4
Ragheb M, Powell A. Lithium interaction with sulindac and naproxen. J Clin Psychopharmacol 1986; 6(3): 150–4
Reimann I, Diener U, Frolich J. Indomethacin but not aspirin increases plasma lithium ion levels. Arch Gen Psychiatry 1983; 40: 283–6
Lacro JP, Eastham JH, Jeste DV, et al. Newer antipsychotics and antidepressants for elderly people. Curr Opin Psychiatry 1996; 9(4): 290–3
Salama AA, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate. Am J Psychiatry 1989; 146(2): 278
Noveske FG, Hahn KR, Flynn RJ. Possible toxicity of combined fluoxetine and lithium. Am J Psychiatry 1989; 146(11): 1515
Vesely C, Fischer P, Goessler R, et al. Mania associated with serotonin selective reuptake inhibitors [letter]. J Clin Psychiatry 1997; 58(2): 88
Chaudhry RP, Waters BGH. Lithium and carbamazepine interaction: possible neurotoxicity. J Clin Psychiatry 1983; 44(1): 30–1
Andrus P. Lithium and carbamazepine. J Clin Psychiatry 1984; 45: 525
Shukla S, Godwin CD, Long LEB, et al. Lithium-carbamazepine neurotoxicity and risk factors. Am J Psychiatry 1984; 141(12): 1604–6
Marcoux AW. Carbamazepine-lithium drug interaction. Ann Pharmacother 1996; 30(5): 547
Perry PJ, Calloway RA, Cook BL. Theophylline precipitated alterations of lithium clearance. Acta Psychiatr Scand 1984; 69: 528–37
Holstad SG, Perry JP, Kathol RG. The effects of intravenous theophylline infusion on lithium clearance in normal subjects. Psychiatry Res 1988; 25: 203–11
Mester R, Toren P, Mizrachi I. Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 1995; 37: 348–50
Sylvester RK, Leitch J, Granum C. Does acyclovir increase serum lithium levels? Pharmacotherapy 1996; 16(3): 466–8
Jelliffe RW. Creatinine clearance: bedside estimate. Ann Intern Med 1973; 79(4): 604–5
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31–41
Risinger RC, Risby ED, Risch SC. Safety and efficacy of divalproex sodium in elderly bipolar patients. J Clin Psychiatry 1994; 55(5): 215
McFarland BH, Miller MR, Straumfjord AA. Valproate use in the older manic patient. J Clin Psychiatry 1990; 51(11): 479–81
Sharma V, Persad E. Augmentation of valproate with lithium in a case of rapid cycling affective disorder. Can J Psychiatry 1992; 37(8): 584–5
Pope HG, McElroy SL, Satlin A. Head injury, bipolar disorder, and response to valproate. Compr Psychiatry 1988; 29: 34–8
Kando JC, Tohen M, Castillo J, et al. The use of valproate in an elderly population with affective symptoms. J Clin Psychiatry 1996; 57(6): 238–40
Gnam W, Flint AJ. New onset rapid cycling bipolar disorder in an 87 year old woman. Can J Psychiatry 1993; 38: 324–6
Rimmer EM, Richens A. An update on sodium valproate. Pharmacotherapy 1985; 5(3): 171–84
Bowden CL, Janicak PG, Orsulak P, et al. Relation of serum valproate concentration to response in mania. Am J Psychiatry 1996; 153(6): 765–70
Lott AD, McElroy SL, Keys MA. Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry 1995; 7(3): 314–9
Bauer LA, Davis R, Wilensky A, et al. Valproic acid clearance: unbound fraction and diurnal variations in young and elderly adults. Clin Pharmacol Ther 1985; 37: 697–700
Redington K, Wells C, Petito F. Erythromycin and valproate interaction. Ann Intern Med 1992; 116(10): 877–8
Levy RH, Koch KM. Drug interactions with valproic acid. Drugs 1982; 24(6): 543–6
Sharma V, Persad E, Mazmanian D, et al. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can J Psychiatry 1993; 38(2): 137–9
Battino D, Bossi L, Croci D, et al. Carbamazepine plasma levels in children and adults: influence of age, dose and associated therapy. Ther Drug Monit 1980; 2(4): 315–22
Ladefoged SD, Mogelvang JC. Total atrioventricular block with syncopes complicating carbamazepine therapy. Acta Med Scand 1982; 212(3): 185–6
Wroblewski BA, Singer WD, Whyte J. Carbamazepine-erythromycin interaction: case studies and clinical significance. JAMA 1986; 255: 1165–7
Brodie MJ, MacPhee GJA. Carbamazepine neurotoxicity precipitated by diltiazem. BMJ 1986; 292: 1170–1
Valsalan VC, Cooper GL. Carbamazepine intoxication caused by interaction with isoniazid. BMJ 1982; 285: 261–2
Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand 1991; 84: 583–4
Joblin M, Ghose K. Possible interaction of sertraline with carbamazepine. N Z Med J 1994; 107: 43
MacPhee GJ, McInnes GT, Thompson GG. Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet 1986; I: 700–3
Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine: an update. Clin Pharmacokinet 1996; 31(3): 198–214
Yassa R, Nastase C, Camille Y, et al. Carbamazepine, diuretics, and hyponatremia: a possible interaction. J Clin Psychiatry 1987; 48(7): 281–3
Frankenburg FR. Clozapine and bipolar disorder. J Clin Psychopharmacol 1993; 13(4): 289–90
Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Pharmacol 1991; 11(6): 396–7
Jeste DV, Eastham JH, Lacro JP, et al. Management of late-life psychosis. J Clin Psychiatry 1996; 57Suppl. 3: 39–45
Cohen WJ, Cohen NH. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA 1974; 230(9): 1283–7
Miller F, Menninger J, Whitcup SM. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient. J Clin Psychopharmacol 1986; 6(3): 176–8
Miller F, Menninger J. Correlation of neuroleptic dose and neurotoxicity in patients given lithium and a neuroleptic. Hosp Community Psychiatry 1987; 38(11): 1219–21
Greenberg L, Fink M. The use of electroconvulsive therapy in geriatric patients. Clin Geriatr Med 1992; 8(2): 349–54
Weiner RD. Does electroconvulsive therapy cause brain damage? Behav Brain Sci 1984; 7: 1–53
Alexopoulos GS, Shamoian CA, Lucas J. Medical problems of geriatric patients and younger controls during electroconvulsive therapy. J Am Geriatr Soc 1984; 32(9): 651–4
Burke WJ, Rubin EH, Zorumski CF, et al. The safety of ECT in geriatric psychiatry. J Am Geriatr Soc 1987; 35(6): 516–21
Kellner CH, Monroe RR, Pritchett J, et al. Weekly ECT in geriatric depression. Convuls Ther 1992; 8(4): 245–52
Sackeim HA, Prudic J, Devanand DP. Effects of stimulus intensity and electrode placement of the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993; 328: 882–3
Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 1994; 151(2): 169–76
Frazer RM, Glass IB. Recovery from ECT in elderly patients. Br J Psychiatry 1978; 133: 524–8
Madden JS. Alcohol and depression. Br J Hosp Med 1993; 50(5): 261–3
Ganzini L, Walsh JR, Millar SB. Drug-induced depression in the aged: what can be done? Drugs Aging 1993; 3(2): 147–58
Biriell C, McEwen J, Sanz E. Depression associated with diltiazem. BMJ 1989; 299: 796
Hullett FJ, Potkin SG, Levy AB, et al. Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry 1988; 145: 1277–9
Eisendrath SJ, Sweeney NA. Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations. Am J Psychiatry 1987; 144: 506–7
Crowser MK, Pate JK. A case report of cimetidine-induced depressive syndrome. Am J Psychiatry 1980; 137: 1451
Jefferson JW. Central nervous system toxicity of cimetidine: a case of depression. Am J Psychiatry 1979; 136: 346
Billings RF, Stein MB. Depression associated with ranitidine. Am J Psychiatry 1986; 143: 915–6
Okada F. Depression after treatment with thiazide diuretics for hypertension. Am J Psychiatry 1988; 142: 1101–2
Himmelhoch JM, Detre T, Kupfer DJ, et al. Treatment of previously intractable depressions with tranylcypromine and lithium. J Nerv Ment Dis 1972; 155: 216–20
Goodwin FK, Jamison KR. Manic depressive illness. New York: Oxford University Press, 1990: 48
Freeman TW, Clothier JL, Pazzaglia P, et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108–11
Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271: 918–24
Gitlin MJ. Lithium-induced renal insufficiency. J Clin Psychopharm 1993; 132(4): 276–9
Hetmar O, Povlsen UJ, Ladefoged J, et al. Lithium: long-term effects on the kidney — a prospective follow-up study ten years after kidney biopsy. Br J Psychiatry 1991; 158: 53–8
Lokkegaard H, Andersen NF, Henriksen E, et al. Renal function in 153 manic-depressive patients treated with lithium for more than five years. Acta Psychiatr Scand 1985; 71: 347–55
Conte G, Vazzola A, Saccetti E. Renal function in chronic lithium-treated patients. Acta Psychiatr Scand 1989; 79: 503–4
Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated 1–30 years. Acta Psychiatr Scand 1995; 91: 48–51
Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Comm Psychopharmacol 1978; 2: 159–75
White E, Cheung P, Silverstone T. Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 1993; 8(2): 119–22
Mirchandani I, Abrams RC, Pollak C, et al. One year follow-up of continuation convulsive therapy prescribed for depressed elderly patients. Int J Geriatr Psychiatry 1994; 9: 31–6
Miklowitz DJ. Psychotherapy in combination with drug treatment for bipolar disorder. J Clin Psychopharmacol 1996; 16Suppl. 1: 56S–66S
Bauer M, McBride L. Psychosocial treatments for bipolar disorder. In: Bauer M, McBride L. Structured group psychotherapy for bipolar disorder: the life goals program. New York: Springer, 1996: 69–83
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eastham, J.H., Jeste, D.V. & Young, R.C. Assessment and Treatment of Bipolar Disorder in the Elderly. Drugs & Aging 12, 205–224 (1998). https://doi.org/10.2165/00002512-199812030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199812030-00004